Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Luis Jara-Palomares (Seville, Spain), Luis Jara-Palomares, Remedios Otero-Candelera, David Jimenez, Marc Carrier, Inna Tzoran, Benjamin Brenner, Manuel Monreal. Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate. Eur Respir J 2016; 48: Suppl. 60, 3603

Member's Comments

No comment yet.

Related content which might interest you: Recurrence patterns for venous thromboembolism - who is most at risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 The diagnosis of malignancy following a venous thromboembolic event - how high is the risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Venous thromboembolism in patients immobilized at home Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 How to prevent VTE in COVID-19 patients?: Chinese & European perspectives Source: ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives Year: 2020 Characteristics of the patiens diagnosed with pulmonary thromboembolism in the last 10 years Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Do we ever learn? Risk stratification and investigation of suspected pulmonary embolism Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Chronic obstructive pulmonary disease and venous thromboembolism recurrents : A prospective study Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial Source: Eur Respir J, 56 (4) 2000663; 10.1183/13993003.00663-2020 Year: 2020 Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study Source: Eur Respir J 2014; 44: 1714-1715 Year: 2014 Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Bilateral chylothorax in a patient with chronic central vein thrombosis and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015